The Wellcome Trust was established in 1936 and headquartered in London, UK. The mission of Wellcome Trust is to foster and promote research with the aim of improving human and animal health. The Wellcome Trust has an endowment of more than 16 billion British Pounds and The Wellcome Trust supports and funds the sequencing of the human genome at the Wellcome Trust Sanger Institute, development of a malaria drug, and other research projects. Wellcome Trust fully supports open access of research papers and reports.
Great genetic variation in pancreatic cancer, study shows
A new study published recently in Nature details the complexity of genetic variation found in pancreatic cancer cells. The ability to identify and understand the early mutations involved with the disease may lead to the discovery ...
Global map of the sickle cell gene supports 'malaria hypothesis'
At a global scale, the sickle cell gene is most commonly found in areas with historically high levels of malaria, adding geographical support to the hypothesis that the gene, whilst potentially deadly, avoids disappearing ...
Major clinical trial prompts call for change to treatment guidelines for severe malaria worldwide
The largest ever clinical trial in patients hospitalised with severe malaria has concluded that the drug artesunate should now be the preferred treatment for the disease in both children and adults everywhere in the world. ...
New antibiotic for hospital superbug looks promising
A new class of antibiotic specifically designed to target the hospital superbug Clostridium difficile has proved to be more effective than current treatments in preclinical studies.
Team finds mutation involved in macular degeneration
Researchers from the Wellcome Trust Centre for Cell-Matrix Research in Manchester have revealed more about how a particular genetic change significantly raises the risk of developing age-related macular degeneration.
Exposure to worm infection in the womb may protect against eczema, study suggests
Exposure to worm infections in the womb may protect a newborn infant from developing eczema, a study funded by the Wellcome Trust suggests. A large trial in Uganda showed that treating a pregnant woman for worm infections ...
HIV clinical trial looks at potential benefits of treating recently-infected patients
For most people in high-income countries HIV is considered a chronic illness which can be managed with medication. But the virus still causes extensive damage to the immune system, and treatment with antiretrovirals is a ...
Robots provide insight into human perception
Research using a robot designed to express human emotions has revealed unexpected insights into how our perception is affected by anthropomorphism, or giving human characteristics to non-human animals or things.
Managing the transition to open access: Report examines the role for intermediaries
A new report from the UK Open Access Implementation Group examines the potential part that intermediaries could play in helping universities, funders and publishers to manage the impact of increasing volumes of open access ...
New antibiotic proves safe and well tolerated
(PhysOrg.com) -- A new antibiotic to combat drug-resistant bacteria has proved safe and well tolerated in a phase I clinical trial with plans for a phase II trial underway.